NeuroEndocrine Cancer Australia

Thank you to BioPharma Dispatch for helping highlight what the new data has confirmed and what NeuroEndocrine Cancer Australia (NECA) has long been warning. Where you live and how much you earn is starting to determine whether you survive neuroendocrine cancer. The findings, drawn from Australian Institute of Health and Welfare figures and covered this […]

We are thrilled to share news our community has been waiting for: a new $3 million national research initiative called PLANETARI has been funded through the Australian Government’s Medical Research Future Fund (MRFF), and it has been built with patients at the centre from day one. For too long, neuroendocrine cancer has been under-recognised and […]

Where you live, and what you earn, could determine your chances of surviving one of Australia’s fastest-growing cancers While it is good to see that current analysis shows a closing of the gap for all cancers combined, for neuroendocrine cancer the gap between those with the best outcomes and those with the worst is widening […]

We’re thrilled to share some exciting news with the NET community. NeuroEndocrine Cancer Australia (NECA), and three of our incredible people, have been entered into the Patients Australia Patient’s Choice Awards 2026! These awards celebrate the very best in patient-centred care across the country, and this year the NET community has six fantastic reasons to […]

On Thursday 25 June 2026 NECA attended the Rare Cancers Event at Parliament House in Canberra. It was great to come together with other Patient Groups, patients with rare cancers and members of Parliament. Many cancers are no longer rare and can be classified as less common – this was acknowledged by Minister Butler, Senator […]